IFITM3 variants point to a critical role in emergent virus infections

ABSTRACT Interferon-induced transmembrane protein 3 (IFITM3) is a cellular protein that restricts numerous viral infections by blocking virus–host membrane fusion. In humans, there are two IFITM3 single nucleotide polymorphisms (SNPs), rs12252-C and rs34481144-A, that decrease IFITM3 activity and ha...

Full description

Saved in:
Bibliographic Details
Main Authors: Parker J. Denz, Jacob S. Yount
Format: Article
Language:English
Published: American Society for Microbiology 2025-05-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mbio.03347-24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850275652885807104
author Parker J. Denz
Jacob S. Yount
author_facet Parker J. Denz
Jacob S. Yount
author_sort Parker J. Denz
collection DOAJ
description ABSTRACT Interferon-induced transmembrane protein 3 (IFITM3) is a cellular protein that restricts numerous viral infections by blocking virus–host membrane fusion. In humans, there are two IFITM3 single nucleotide polymorphisms (SNPs), rs12252-C and rs34481144-A, that decrease IFITM3 activity and have been associated with severe illness following influenza virus infections. Mice lacking IFITM3 show increased influenza severity, supporting this association. However, some studies do not find a consistent link between IFITM3 SNPs and infection severity, causing uncertainty about its role in vivo. Review of the literature indicates that IFITM3 SNPs are primarily associated with increased viral disease in infections with emergent influenza viruses, such as the 2009 H1N1 pandemic virus and zoonotic H7N9 virus. Similarly, IFITM3 SNPs are reported to be risk factors for increased severity in other emergent infections, including SARS-CoV-2, Hantaan virus, and HIV. In contrast, most studies that failed to find an association examined seasonal influenza. We posit that adaptive immune mechanisms, including pre-existing antibodies and memory T cells against seasonally circulating viruses, compensate for IFITM3 deficiencies, therefore masking its role in seasonal influenza. We propose that IFITM3 is most critical in defending against emergent viruses and should be a key focus of public health strategies to prevent the emergence and spread of novel pathogens, with individuals carrying IFITM3 SNPs potentially benefiting from broadened vaccine coverage, avoidance of animal reservoirs, or enhanced masking to protect themselves and the wider population.
format Article
id doaj-art-ed51bc5b246c45f2966b25db7e5f2cb1
institution OA Journals
issn 2150-7511
language English
publishDate 2025-05-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj-art-ed51bc5b246c45f2966b25db7e5f2cb12025-08-20T01:50:39ZengAmerican Society for MicrobiologymBio2150-75112025-05-0116510.1128/mbio.03347-24IFITM3 variants point to a critical role in emergent virus infectionsParker J. Denz0Jacob S. Yount1Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USADepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USAABSTRACT Interferon-induced transmembrane protein 3 (IFITM3) is a cellular protein that restricts numerous viral infections by blocking virus–host membrane fusion. In humans, there are two IFITM3 single nucleotide polymorphisms (SNPs), rs12252-C and rs34481144-A, that decrease IFITM3 activity and have been associated with severe illness following influenza virus infections. Mice lacking IFITM3 show increased influenza severity, supporting this association. However, some studies do not find a consistent link between IFITM3 SNPs and infection severity, causing uncertainty about its role in vivo. Review of the literature indicates that IFITM3 SNPs are primarily associated with increased viral disease in infections with emergent influenza viruses, such as the 2009 H1N1 pandemic virus and zoonotic H7N9 virus. Similarly, IFITM3 SNPs are reported to be risk factors for increased severity in other emergent infections, including SARS-CoV-2, Hantaan virus, and HIV. In contrast, most studies that failed to find an association examined seasonal influenza. We posit that adaptive immune mechanisms, including pre-existing antibodies and memory T cells against seasonally circulating viruses, compensate for IFITM3 deficiencies, therefore masking its role in seasonal influenza. We propose that IFITM3 is most critical in defending against emergent viruses and should be a key focus of public health strategies to prevent the emergence and spread of novel pathogens, with individuals carrying IFITM3 SNPs potentially benefiting from broadened vaccine coverage, avoidance of animal reservoirs, or enhanced masking to protect themselves and the wider population.https://journals.asm.org/doi/10.1128/mbio.03347-24IFITM3influenza virusSARS-CoV-2innate immunitySNPemerging viruses
spellingShingle Parker J. Denz
Jacob S. Yount
IFITM3 variants point to a critical role in emergent virus infections
mBio
IFITM3
influenza virus
SARS-CoV-2
innate immunity
SNP
emerging viruses
title IFITM3 variants point to a critical role in emergent virus infections
title_full IFITM3 variants point to a critical role in emergent virus infections
title_fullStr IFITM3 variants point to a critical role in emergent virus infections
title_full_unstemmed IFITM3 variants point to a critical role in emergent virus infections
title_short IFITM3 variants point to a critical role in emergent virus infections
title_sort ifitm3 variants point to a critical role in emergent virus infections
topic IFITM3
influenza virus
SARS-CoV-2
innate immunity
SNP
emerging viruses
url https://journals.asm.org/doi/10.1128/mbio.03347-24
work_keys_str_mv AT parkerjdenz ifitm3variantspointtoacriticalroleinemergentvirusinfections
AT jacobsyount ifitm3variantspointtoacriticalroleinemergentvirusinfections